Cencora Inc traded at $309.93 this Monday March 30th, decreasing $2.52 or 0.81 percent since the previous trading session. Looking back, over the last four weeks, Cencora lost 16.83 percent. Over the last 12 months, its price rose by 11.45 percent. Looking ahead, we forecast Cencora Inc to be priced at 303.08 by the end of this quarter and at 276.61 in one year, according to Trading Economics global macro models projections and analysts expectations.
Cencora, Inc. is a global pharmaceutical sourcing and distribution services company. The Company is focused on improving the lives of people and animals around the world. It is engaged in the delivery of pharmaceuticals, healthcare products, and solutions. The Company operates through two segments: U.S. Healthcare Solutions and International Healthcare Solutions. The U.S. Healthcare Solutions segment distributes a comprehensive offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a variety of healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, long-term care and alternate site pharmacies, and other customers. The International Healthcare Solutions segment consists of businesses that focus on international pharmaceutical wholesale and related service operations and global commercialization services.